Skip to main content
Top
Published in: Journal of Neuro-Oncology 2/2017

01-09-2017 | Clinical Study

Natural history of optic pathway gliomas in a cohort of unselected patients affected by Neurofibromatosis 1

Authors: Eva Trevisson, Matteo Cassina, Enrico Opocher, Virginia Vicenzi, Marta Lucchetta, Raffaele Parrozzani, Giacomo Miglionico, Rodica Mardari, Elisabetta Viscardi, Edoardo Midena, Maurizio Clementi

Published in: Journal of Neuro-Oncology | Issue 2/2017

Login to get access

Abstract

Optic pathway glioma (OPG) represents the most common central nervous system tumor in children with Neurofibromatosis type-1 (NF1). Although overall survival is usually good, no clear prognostic factors have been identified so far. We assessed the natural history of OPG in a cohort of unselected patients affected by NF1. We retrospectively evaluated 414 consecutive patients affected by NF1 and referred to our NF1 clinic before age 6. Average follow-up was 11.9 years: 52 out of 414 patients had OPG with a total cumulative incidence of 15.4% at age 15 (Kaplan–Meier estimate) and a statistically significant difference according to sex. Brain and orbit MRI was performed in 44.7% of patients: 34.6% for screening purposes and 65.4% because of the presence of neurological, ocular or other symptoms. OPG was diagnosed in 12.5% of cases in the first group, whereas in 36.4% in the latter group (p = 0.001). Clinical management was conservative in most patients, while 8 of them underwent therapy mainly because of visual deterioration. OPG was diagnosed earlier in treated patients, but the difference was not statistically significant. Conversely, all patients who underwent screening MRI had normal visual outcome. In conclusion, OPG location does not correlate with need for treatment; female patients were more frequently affected by OPG but not more frequently treated. OPG diagnosis by screening MRI does not affect the natural history of the tumor.
Appendix
Available only for authorised users
Literature
1.
go back to reference Clementi M, Barbujani G, Turolla L, Tenconi R (1990) Neurofibromatosis-1: a maximum likelihood estimation of mutation rate. Hum Genet 84(2):116–118CrossRefPubMed Clementi M, Barbujani G, Turolla L, Tenconi R (1990) Neurofibromatosis-1: a maximum likelihood estimation of mutation rate. Hum Genet 84(2):116–118CrossRefPubMed
2.
go back to reference Wallace MR, Marchuk DA, Andersen LB, Letcher R, Odeh HM, Saulino AM, Fountain JW, Brereton A, Nicholson J, Mitchell AL, Brownstein BH, Collins FS (1990) Type-1 Neurofibromatosis gene—identification of a large transcript disrupted in 3 Nf1 patients. Science 249(4965):181–186. doi:10.1126/science.2134734 CrossRefPubMed Wallace MR, Marchuk DA, Andersen LB, Letcher R, Odeh HM, Saulino AM, Fountain JW, Brereton A, Nicholson J, Mitchell AL, Brownstein BH, Collins FS (1990) Type-1 Neurofibromatosis gene—identification of a large transcript disrupted in 3 Nf1 patients. Science 249(4965):181–186. doi:10.​1126/​science.​2134734 CrossRefPubMed
5.
go back to reference Ferner RE, Huson SM, Thomas N, Moss C, Willshaw H, Evans DG, Upadhyaya M, Towers R, Gleeson M, Steiger C, Kirby A (2007) Guidelines for the diagnosis and management of individuals with Neurofibromatosis 1. J Med Genet 44(2):81–88. doi:10.1136/jmg.2006.045906 CrossRefPubMed Ferner RE, Huson SM, Thomas N, Moss C, Willshaw H, Evans DG, Upadhyaya M, Towers R, Gleeson M, Steiger C, Kirby A (2007) Guidelines for the diagnosis and management of individuals with Neurofibromatosis 1. J Med Genet 44(2):81–88. doi:10.​1136/​jmg.​2006.​045906 CrossRefPubMed
6.
go back to reference Listernick R, Louis DN, Packer RJ, Gutmann DH (1997) Optic pathway gliomas in children with Neurofibromatosis 0.1. Consensus statement from the NF1 optic pathway glioma task force. Ann Neurol 41(2):143–149. doi:10.1002/ana.410410204 CrossRefPubMed Listernick R, Louis DN, Packer RJ, Gutmann DH (1997) Optic pathway gliomas in children with Neurofibromatosis 0.1. Consensus statement from the NF1 optic pathway glioma task force. Ann Neurol 41(2):143–149. doi:10.​1002/​ana.​410410204 CrossRefPubMed
8.
go back to reference Listernick R, Ferner RE, Piersall L, Sharif S, Gutmann DH, Charrow J (2004) Late-onset optic pathway tumors in children with neurofibromatosis 1. Neurology 63(10):1944–1946CrossRefPubMed Listernick R, Ferner RE, Piersall L, Sharif S, Gutmann DH, Charrow J (2004) Late-onset optic pathway tumors in children with neurofibromatosis 1. Neurology 63(10):1944–1946CrossRefPubMed
10.
11.
go back to reference Balcer LJ, Liu GT, Heller G, Bilaniuk L, Volpe NJ, Galetta SL, Molloy PT, Phillips PC, Janss AJ, Vaughn S, Maguire MG (2001) Visual loss in children with neurofibromatosis type 1 and optic pathway gliomas: relation to tumor location by magnetic resonance imaging. Am J Ophthalmol 131(4):442–445CrossRefPubMed Balcer LJ, Liu GT, Heller G, Bilaniuk L, Volpe NJ, Galetta SL, Molloy PT, Phillips PC, Janss AJ, Vaughn S, Maguire MG (2001) Visual loss in children with neurofibromatosis type 1 and optic pathway gliomas: relation to tumor location by magnetic resonance imaging. Am J Ophthalmol 131(4):442–445CrossRefPubMed
12.
go back to reference Taylor T, Jaspan T, Milano G, Gregson R, Parker T, Ritzmann T, Benson C, Walker D, Group PS (2008) Radiological classification of optic pathway gliomas: experience of a modified functional classification system. Br J Radiol 81(970):761–766. doi:10.1259/bjr/65246351 CrossRefPubMed Taylor T, Jaspan T, Milano G, Gregson R, Parker T, Ritzmann T, Benson C, Walker D, Group PS (2008) Radiological classification of optic pathway gliomas: experience of a modified functional classification system. Br J Radiol 81(970):761–766. doi:10.​1259/​bjr/​65246351 CrossRefPubMed
13.
go back to reference Fisher MJ, Loguidice M, Gutmann DH, Listernick R, Ferner RE, Ullrich NJ, Packer RJ, Tabori U, Hoffman RO, Ardern-Holmes SL, Hummel TR, Hargrave DR, Bouffet E, Charrow J, Bilaniuk LT, Balcer LJ, Liu GT (2012) Visual outcomes in children with neurofibromatosis type 1-associated optic pathway glioma following chemotherapy: a multicenter retrospective analysis. Neuro Oncol 14(6):790–797. doi:10.1093/neuonc/nos076 CrossRefPubMedPubMedCentral Fisher MJ, Loguidice M, Gutmann DH, Listernick R, Ferner RE, Ullrich NJ, Packer RJ, Tabori U, Hoffman RO, Ardern-Holmes SL, Hummel TR, Hargrave DR, Bouffet E, Charrow J, Bilaniuk LT, Balcer LJ, Liu GT (2012) Visual outcomes in children with neurofibromatosis type 1-associated optic pathway glioma following chemotherapy: a multicenter retrospective analysis. Neuro Oncol 14(6):790–797. doi:10.​1093/​neuonc/​nos076 CrossRefPubMedPubMedCentral
14.
go back to reference Tow SL, Chandela S, Miller NR, Avellino AM (2003) Long-term outcome in children with gliomas of the anterior visual pathway. Pediatr Neurol 28(4):262–270CrossRefPubMed Tow SL, Chandela S, Miller NR, Avellino AM (2003) Long-term outcome in children with gliomas of the anterior visual pathway. Pediatr Neurol 28(4):262–270CrossRefPubMed
15.
18.
go back to reference Blanchard G, Lafforgue MP, Lion-Francois L, Kemlin I, Rodriguez D, Castelnau P, Carneiro M, Meyer P, Rivier F, Barbarot S, Chaix Y, network NFF (2016) Systematic MRI in NF1 children under six years of age for the diagnosis of optic pathway gliomas. Study and outcome of a French cohort. Eur J Paediatr Neurol 20(2):275–281. doi:10.1016/j.ejpn.2015.12.002 CrossRefPubMed Blanchard G, Lafforgue MP, Lion-Francois L, Kemlin I, Rodriguez D, Castelnau P, Carneiro M, Meyer P, Rivier F, Barbarot S, Chaix Y, network NFF (2016) Systematic MRI in NF1 children under six years of age for the diagnosis of optic pathway gliomas. Study and outcome of a French cohort. Eur J Paediatr Neurol 20(2):275–281. doi:10.​1016/​j.​ejpn.​2015.​12.​002 CrossRefPubMed
19.
20.
go back to reference Dalla Via P, Opocher E, Pinello ML, Calderone M, Viscardi E, Clementi M, Battistella PA, Laverda AM, Da Dalt L, Perilongo G (2007) Visual outcome of a cohort of children with Neurofibromatosis type 1 and optic pathway glioma followed by a pediatric neuro-oncology program. Neuro Oncol 9(4):430–437. doi:10.1215/15228517-2007-031 CrossRefPubMed Dalla Via P, Opocher E, Pinello ML, Calderone M, Viscardi E, Clementi M, Battistella PA, Laverda AM, Da Dalt L, Perilongo G (2007) Visual outcome of a cohort of children with Neurofibromatosis type 1 and optic pathway glioma followed by a pediatric neuro-oncology program. Neuro Oncol 9(4):430–437. doi:10.​1215/​15228517-2007-031 CrossRefPubMed
21.
go back to reference Kalin-Hajdu E, Decarie JC, Marzouki M, Carret AS, Ospina LH (2014) Visual acuity of children treated with chemotherapy for optic pathway gliomas. Pediatr Blood Cancer 61(2):223–227. doi:10.1002/pbc.24726 CrossRefPubMed Kalin-Hajdu E, Decarie JC, Marzouki M, Carret AS, Ospina LH (2014) Visual acuity of children treated with chemotherapy for optic pathway gliomas. Pediatr Blood Cancer 61(2):223–227. doi:10.​1002/​pbc.​24726 CrossRefPubMed
22.
go back to reference Neurofibromatosis. Conference statement. National Institutes of Health Consensus Development Conference (1988) Arch Neurol 45(5):575–578 Neurofibromatosis. Conference statement. National Institutes of Health Consensus Development Conference (1988) Arch Neurol 45(5):575–578
24.
go back to reference Parrozzani R, Clementi M, Kotsafti O, Miglionico G, Trevisson E, Orlando G, Pilotto E, Midena E (2013) Optical coherence tomography in the diagnosis of optic pathway gliomas. Invest Ophthalmol Vis Sci 54(13):8112–8118. doi:10.1167/iovs.13-13093 CrossRefPubMed Parrozzani R, Clementi M, Kotsafti O, Miglionico G, Trevisson E, Orlando G, Pilotto E, Midena E (2013) Optical coherence tomography in the diagnosis of optic pathway gliomas. Invest Ophthalmol Vis Sci 54(13):8112–8118. doi:10.​1167/​iovs.​13-13093 CrossRefPubMed
25.
go back to reference Pan Y, Tarczy-Hornoch K, Cotter SA, Wen G, Borchert MS, Azen SP, Varma R, Grp M (2009) Visual acuity norms in pre-school children: the multi-ethnic pediatric eye disease study. Optom Vis Sci 86 (6):607–612CrossRefPubMedPubMedCentral Pan Y, Tarczy-Hornoch K, Cotter SA, Wen G, Borchert MS, Azen SP, Varma R, Grp M (2009) Visual acuity norms in pre-school children: the multi-ethnic pediatric eye disease study. Optom Vis Sci 86 (6):607–612CrossRefPubMedPubMedCentral
26.
go back to reference International Classification of Impairments, Disabilities, and Handicaps. A manual of classification relating to the consequences of disease (1980). World Health Organization 1980 edn International Classification of Impairments, Disabilities, and Handicaps. A manual of classification relating to the consequences of disease (1980). World Health Organization 1980 edn
27.
go back to reference Friedrich RE, Nuding MA (2016) Optic pathway glioma and cerebral focal abnormal signal intensity in patients with Neurofibromatosis type 1: characteristics, treatment choices and follow-up in 134 affected individuals and a brief review of the literature. Anticancer Res 36(8):4095–4121PubMed Friedrich RE, Nuding MA (2016) Optic pathway glioma and cerebral focal abnormal signal intensity in patients with Neurofibromatosis type 1: characteristics, treatment choices and follow-up in 134 affected individuals and a brief review of the literature. Anticancer Res 36(8):4095–4121PubMed
28.
go back to reference Sharif S, Ferner R, Birch JM, Gillespie JE, Gattamaneni HR, Baser ME, Evans DG (2006) Second primary tumors in neurofibromatosis 1 patients treated for optic glioma: substantial risks after radiotherapy. J Clin Oncol 24(16):2570–2575. doi:10.1200/JCO.2005.03.8349 CrossRefPubMed Sharif S, Ferner R, Birch JM, Gillespie JE, Gattamaneni HR, Baser ME, Evans DG (2006) Second primary tumors in neurofibromatosis 1 patients treated for optic glioma: substantial risks after radiotherapy. J Clin Oncol 24(16):2570–2575. doi:10.​1200/​JCO.​2005.​03.​8349 CrossRefPubMed
29.
go back to reference Dodge HW Jr, Love JG, Craig WM, Dockerty MB, Kearns TP, Holman CB, Hayles AB (1958) Gliomas of the optic nerves. AMA. Arch Neurol Psychiatry 79(6):607–621CrossRef Dodge HW Jr, Love JG, Craig WM, Dockerty MB, Kearns TP, Holman CB, Hayles AB (1958) Gliomas of the optic nerves. AMA. Arch Neurol Psychiatry 79(6):607–621CrossRef
31.
go back to reference Johnson KJ, Scheurer ME, Woehrer A, Wiemels J (2016) Evolving evidence on tumor and germline genetic classification of gliomas: implications for etiology and survival studies. Clin Neuropathol 35(1):31–38. doi:10.5414/NP300917 CrossRefPubMed Johnson KJ, Scheurer ME, Woehrer A, Wiemels J (2016) Evolving evidence on tumor and germline genetic classification of gliomas: implications for etiology and survival studies. Clin Neuropathol 35(1):31–38. doi:10.​5414/​NP300917 CrossRefPubMed
33.
go back to reference Blazo MA, Lewis RA, Chintagumpala MM, Frazier M, McCluggage C, Plon SE (2004) Outcomes of systematic screening for optic pathway tumors in children with Neurofibromatosis Type 1. Am J Med Genet A 127 A(3):224–229. doi:10.1002/ajmg.a.20650 CrossRef Blazo MA, Lewis RA, Chintagumpala MM, Frazier M, McCluggage C, Plon SE (2004) Outcomes of systematic screening for optic pathway tumors in children with Neurofibromatosis Type 1. Am J Med Genet A 127 A(3):224–229. doi:10.​1002/​ajmg.​a.​20650 CrossRef
34.
go back to reference Massry GG, Morgan CF, Chung SM (1997) Evidence of optic pathway gliomas after previously negative neuroimaging. Ophthalmology 104(6):930–935CrossRefPubMed Massry GG, Morgan CF, Chung SM (1997) Evidence of optic pathway gliomas after previously negative neuroimaging. Ophthalmology 104(6):930–935CrossRefPubMed
35.
go back to reference Listernick R, Charrow J, Greenwald M (1992) Emergence of optic pathway gliomas in children with neurofibromatosis type 1 after normal neuroimaging results. J Pediatr 121(4):584–587CrossRefPubMed Listernick R, Charrow J, Greenwald M (1992) Emergence of optic pathway gliomas in children with neurofibromatosis type 1 after normal neuroimaging results. J Pediatr 121(4):584–587CrossRefPubMed
36.
go back to reference Doganis D, Pourtsidis A, Tsakiris K, Baka M, Kouri A, Bouhoutsou D, Varvoutsi M, Servitzoglou M, Dana H, Kosmidis H (2016) Optic pathway glioma in children: 10 years of experience in a single institution. Pediatr Hematol Oncol 33(2):102–108. doi:10.3109/08880018.2016.1155101 CrossRefPubMed Doganis D, Pourtsidis A, Tsakiris K, Baka M, Kouri A, Bouhoutsou D, Varvoutsi M, Servitzoglou M, Dana H, Kosmidis H (2016) Optic pathway glioma in children: 10 years of experience in a single institution. Pediatr Hematol Oncol 33(2):102–108. doi:10.​3109/​08880018.​2016.​1155101 CrossRefPubMed
37.
go back to reference Gottschalk S, Tavakolian R, Buske A, Tinschert S, Lehmann R (1999) Spontaneous remission of chiasmatic/hypothalamic masses in Neurofibromatosis type 1: report of two cases. Neuroradiology 41(3):199–201CrossRefPubMed Gottschalk S, Tavakolian R, Buske A, Tinschert S, Lehmann R (1999) Spontaneous remission of chiasmatic/hypothalamic masses in Neurofibromatosis type 1: report of two cases. Neuroradiology 41(3):199–201CrossRefPubMed
38.
go back to reference Parsa CF, Hoyt CS, Lesser RL, Weinstein JM, Strother CM, Muci-Mendoza R, Ramella M, Manor RS, Fletcher WA, Repka MX, Garrity JA, Ebner RN, Monteiro MLR, McFadzean RM, Rubtsova IV, Hoyt WF (2001) Spontaneous regression of optic gliomas—thirteen cases documented by serial neuroimaging. Arch Ophthalmol-Chic 119(4):516–529CrossRef Parsa CF, Hoyt CS, Lesser RL, Weinstein JM, Strother CM, Muci-Mendoza R, Ramella M, Manor RS, Fletcher WA, Repka MX, Garrity JA, Ebner RN, Monteiro MLR, McFadzean RM, Rubtsova IV, Hoyt WF (2001) Spontaneous regression of optic gliomas—thirteen cases documented by serial neuroimaging. Arch Ophthalmol-Chic 119(4):516–529CrossRef
Metadata
Title
Natural history of optic pathway gliomas in a cohort of unselected patients affected by Neurofibromatosis 1
Authors
Eva Trevisson
Matteo Cassina
Enrico Opocher
Virginia Vicenzi
Marta Lucchetta
Raffaele Parrozzani
Giacomo Miglionico
Rodica Mardari
Elisabetta Viscardi
Edoardo Midena
Maurizio Clementi
Publication date
01-09-2017
Publisher
Springer US
Published in
Journal of Neuro-Oncology / Issue 2/2017
Print ISSN: 0167-594X
Electronic ISSN: 1573-7373
DOI
https://doi.org/10.1007/s11060-017-2517-6

Other articles of this Issue 2/2017

Journal of Neuro-Oncology 2/2017 Go to the issue